Article

Radiation may have potential to treat subfoveal CNV

Augusta, GA-Despite negative results in an early trial, effortsare continuing to determine whether external-beam irradiation can slow visionloss caused by subfoveal choroidal neovascularization (CNV) in age-relatedmacular degeneration (AMD), said Dennis M. Marcus, MD.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
(mage credit: Ophthalmology Times) S. Robert Levine, MD, on the DRD Cure Accelerator: A global moonshot for retinal disease
(Image credit: Ophthalmology Times) CCOI sets the stage for global ophthalmic innovation at Stanford Summit on July 23
(Image credit: Ophthalmology Times) Accelerating eye health innovation through CCOI – Stanford Summit
Related Content
What the eyes reveal: Cardiovascular clues in women—hidden in plain sight
August 13th 2025

What the eyes reveal: Cardiovascular clues in women—hidden in plain sight

3 Things You Should Know About the GA Pipeline
August 13th 2025

3 Things You Should Know About Interventional Glaucoma Comanagement

(Image credit: AdobeStock/zabhie) AI applications in cataract surgery: A surgeon’s perspective
August 13th 2025

AI applications in cataract surgery: A surgeon’s perspective

Patient-Centered Treatment Strategies in the Management of nAMD and DME
August 13th 2025

Patient-Centered Treatment Strategies in the Management of nAMD and DME

(Image credit: Wills Eye Hospital) Wills Eye Hospital names Julia A. Haller, MD, as new chief executive officer
August 13th 2025

Wills Eye Hospital names Julia A. Haller, MD, as new chief executive officer

(Image credit: AdobeStock/Bonsales) Q&A: Natalie Afshari, MD, FACS, on-label pediatric IOLs: turning advocacy into access
August 13th 2025

Q&A: Natalie Afshari, MD, FACS, championing on-label pediatric IOLs: turning advocacy into access

© 2025 MJH Life Sciences

All rights reserved.